Clinical Trial Update: Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)

View source ↗

Summary

A Beijing Anzhen Hospital-led clinical trial aims to develop a risk prediction model for coronary artery disease based on coronary imaging and metabolic indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Status: NOT_YET_RECRUITING